Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus (Q34256560)

31 July 2017

Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus (English)

1 reference

31 July 2017

0 references

0 references

Zaid Al-Hamodi

1

1 reference

31 July 2017

Molham Al-Habori

series ordinal

2

1 reference

31 July 2017

Ali Al-Meeri

series ordinal

3

1 reference

31 July 2017

Riyadh Saif-Ali

series ordinal

4

1 reference

31 July 2017

16 September 2014

1 reference

Diabetology and Metabolic Syndrome

31 July 2017

1 reference

31 July 2017

6

1 reference

31 July 2017

1

1 reference

31 July 2017

99

1 reference

https://scigraph.springernature.com/pub.10.1186/1758-5996-6-99

31 July 2017

0 references

cites work

Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Obesity and C-reactive protein in various populations: a systematic review and meta-analysis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Anti-inflammatory and anti-atherogenic properties of adiponectin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin: mechanistic insights and clinical implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Inflammation and type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Type 2 diabetes as an inflammatory disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Leptin: a pivotal regulator of human energy homeostasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adipocytokines and the metabolic complications of obesity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Role of body fat distribution and the metabolic complications of obesity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

The role of inflammatory cytokines in diabetes and its complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Mechanisms of leptin action and leptin resistance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Type 2 diabetes: principles of pathogenesis and therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Leptin, from fat to inflammation: old questions and new insights.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Relationship between adipocyte size and adipokine expression and secretion

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Low-grade inflammation, obesity, and insulin resistance in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Leptin and incident type 2 diabetes: risk or protection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Insulin decreases human adiponectin plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Relationship between serum adiponectin and leptin concentrations and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Association between fasting glucose and C-reactive protein in middle-aged subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Adiponectin, type 2 diabetes and cardiovascular risk

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Changes in adiponectin level and fat distribution in patients with type 2 diabetes.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Serum levels of leptin, adiponectin, retinol binding protein 4 and leptin/adiponectin molar ratio as another possible marker of insulin resistance in obese

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Adiponectin as a biomarker of the metabolic syndrome

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4177707

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-5996-6-99

Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25276234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Impact of Leptin and Adiponectin on Incident Type 2 Diabetes Is Modified by Sex and Insulin Resistance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25276234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1758-5996-6-99

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference